Intestinal Research

IBD
Is Clostridium difficile infection a real threat in patients with ulcerative colitis? A prospective, multicenter study in Korea: Dae Bum Kim, Kang-Moon Lee, Sang Hyoung Park, You Sun Kim, Eun Soo Kim, Jun Lee, Sung-Ae Jung, Geom Seog Seo, Ji Min Lee; Intest Res. 2018;16(2):267-272. Published online April 30, 2018; DOI: https://doi.org/10.5217/ir.2018.16.2.267
Cited By 1; Full text PubReader ePub Crossref - TDM PDF

Comparison of efficacy of once daily multimatrix mesalazine 2.4 g/day and 4.8 g/day with other 5-aminosalicylic acid preparation in active ulcerative colitis: a randomized, double-blind study: Haruhiko Ogata, Tadashi Yokoyama, Seiichi Mizushima, Atsushi Hagino, Toshifumi Hibi; Intest Res. 2018;16(2):255-266. Published online April 30, 2018; DOI: https://doi.org/10.5217/ir.2018.16.2.255
Cited By 7; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Tofacitinib induction and maintenance therapy in East Asian patients with active ulcerative colitis: subgroup analyses from three phase 3 multinational studies: Satoshi Motoya, Mamoru Watanabe, Hyo Jong Kim, Young Ho Kim, Dong Soo Han, Hirotoshi Yuasa, Junichi Tabira, Naoki Isogawa, Shoko Arai, Isao Kawaguchi, Toshifumi Hibi; Intest Res. 2018;16(2):233-245. Published online April 30, 2018; DOI: https://doi.org/10.5217/ir.2018.16.2.233
Cited By 12; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Trough level of infliximab is useful for assessing mucosal healing in Crohn's disease: a prospective cohort study: Akihiro Koga, Toshiyuki Matsui, Noritaka Takatsu, Yasumichi Takada, Masahiro Kishi, Yutaka Yano, Takahiro Beppu, Yoichiro Ono, Kazeo Ninomiya, Fumihito Hirai, Takashi Nagahama, Takashi Hisabe, Yasuhiro Takaki, Kenshi Yao, Hirotsugu Imaeda, Akira Andoh; Intest Res. 2018;16(2):223-232. Published online April 30, 2018; DOI: https://doi.org/10.5217/ir.2018.16.2.223
Cited By 9; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Characteristics and management of patients with inflammatory bowel disease between a secondary and tertiary hospitals: a propensity score analysis: Ki Hwan Song, Eun Soo Kim, Yoo Jin Lee, Byung Ik Jang, Kyeong Ok Kim, Sang Gyu Kwak, Hyun Seok Lee,; Intest Res. 2018;16(2):216-222. Published online April 30, 2018; DOI: https://doi.org/10.5217/ir.2018.16.2.216
Cited By 2; Full text PubReader ePub Crossref - TDM PDF

Why is it so difficult to evaluate faecal microbiota transplantation as a treatment for ulcerative colitis?: Natalie Grace Fairhurst, Simon P. L. Travis; Intest Res. 2018;16(2):209-215. Published online April 30, 2018; DOI: https://doi.org/10.5217/ir.2018.16.2.209
Cited By 7; Full text PubReader ePub Crossref - TDM PDF

Management of inflammatory bowel disease in older persons: evolving paradigms: Saurabh Kedia, Jimmy K. Limdi, Vineet Ahuja; Intest Res. 2018;16(2):194-208. Published online April 30, 2018; DOI: https://doi.org/10.5217/ir.2018.16.2.194
Cited By 10; Full text PubReader ePub Crossref - TDM PDF

Evidence-based consensus on opportunistic infections in inflammatory bowel disease (republication): Intest Res. 2018;16(2):178-193. Published online April 30, 2018; DOI: https://doi.org/10.5217/ir.2018.16.2.178
Cited By 11; Full text PubReader ePub Crossref - TDM PDF

Predicting outcomes to optimize disease management in inflammatory bowel disease in Japan: their differences and similarities to Western countries: Taku Kobayashi, Tadakazu Hisamatsu, Yasuo Suzuki, Haruhiko Ogata, Akira Andoh, Toshimitsu Araki, Ryota Hokari, Hideki Iijima, Hiroki Ikeuchi, Yoh Ishiguro, Shingo Kato, Reiko Kunisaki, Takayuki Matsumoto, Satoshi Motoya, Masakazu Nagahori, Shiro Nakamura, Hiroshi Nakase, Tomoyuki Tsujikawa, Makoto Sasaki, Kaoru Yokoyama, Naoki Yoshimura, Kenji Watanabe, Miiko Katafuchi, Mamoru Watanabe, Toshifumi Hibi; Intest Res. 2018;16(2):168-177. Published online April 30, 2018; DOI: https://doi.org/10.5217/ir.2018.16.2.168
Cited By 6; Full text PubReader ePub Crossref - TDM PDF

Is once daily multimatrix mesalazine therapy effective regardless of the dose in patients with mild to moderate ulcerative colitis?: Seong Ran Jeon; Intest Res. 2018;16(2):163-165. Published online April 30, 2018; DOI: https://doi.org/10.5217/ir.2018.16.2.163
Cited By 1; Full text PubReader ePub Crossref - TDM PDF

T-cell immune response against cytomegalovirus in peripheral blood and colonic mucosa from ulcerative colitis and Crohn's disease patients: Seung-Joo Nam, Eun Sun Kim, Yoon Tae Jeen; Intest Res. 2018;16(1):160-162. Published online January 18, 2018; DOI: https://doi.org/10.5217/ir.2018.16.1.160; Full text PubReader ePub Crossref - TDM PDF

Hyperbaric oxygen therapy for pyoderma gangrenosum associated with ulcerative colitis: Hyun Il Seo, Hyun-Ju Lee, Koon Hee Han; Intest Res. 2018;16(1):155-157. Published online January 18, 2018; DOI: https://doi.org/10.5217/ir.2018.16.1.155
Cited By 8; Full text PubReader ePub Crossref - TDM PDF

Duodenal amyloidosis secondary to ulcerative colitis: Seung Woon Park, Sam Ryong Jee, Ji Hyun Kim, Sang Heon Lee, Jin Won Hwang, Ji Geon Jang, Dong Woo Lee, Sang Yong Seol; Intest Res. 2018;16(1):151-154. Published online January 18, 2018; DOI: https://doi.org/10.5217/ir.2018.16.1.151
Cited By 4; Full text PubReader ePub Crossref - TDM PDF

A case of pemphigus vulgaris associated with ulcerative colitis: Joo Wan Seo, Jongha Park, Jin Lee, Mi Young Kim, Hyun Ju Choi, Heui Jeong Jeong, Ji Woon Lee, So Young Jung, Woo Kyeong Kim; Intest Res. 2018;16(1):147-150. Published online January 18, 2018; DOI: https://doi.org/10.5217/ir.2018.16.1.147
Cited By 1; Full text PubReader ePub Crossref - TDM PDF

Fecal microbiota transplantation for recurrent Clostridium difficile infection in a patient with ulcerative colitis: Kosaku Nanki, Shinta Mizuno, Katsuyoshi Matsuoka, Keiko Ono, Shinya Sugimoto, Hiroki Kiyohara, Mari Arai, Moeko Nakashima, Kozue Takeshita, Keiichiro Saigusa, Mitsutoshi Senoh, Tadashi Fukuda, Makoto Naganuma, Haru Kato, Wataru Suda, Masahira Hattori, Takanori Kanai; Intest Res. 2018;16(1):142-146. Published online January 18, 2018; DOI: https://doi.org/10.5217/ir.2018.16.1.142
Cited By 4; Full text PubReader ePub Crossref - TDM PDF

IBD